Skip to Main Content

Akili Interactive, the maker of a Food and Drug Administration-cleared video game to treat ADHD, has long been bullish on the tremendous potential of its technology to reach wide swaths of the population. The difficulty of realizing that dream was laid bare in the company’s freshly filed paperwork as it looks to go public.

In January, Akili announced that it would enter the markets via a merger with Social Capital Suvretta Holdings Corp. I, a special purpose acquisition company run by venture capitalist and former Facebook executive Chamath Palihapitiya. The deal valued the company at about $1 billion. On Monday, the companies filed an S-4 with the Securities Exchange Commission detailing the merger and giving the first good look at Akili’s finances and a thorough accounting of the hurdles that the company – and some of Akili’s competitors – could face.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment